Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Harrington

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
American Journal of Blood Research|July 5, 2012
Time and temperature stability of T-cell subsets evaluated by a dual-platform methodHoratiu Olteanu, Bernard C Schur, Alexandra M Harrington, et al.
British Journal of Haematology|May 12, 2010
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemiaHoratiu Olteanu, Alexandra M Harrington, Sarah Ramirez, et al.
Annals of Diagnostic Pathology|July 5, 2011
Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32)J Noelle Buonaccorsi, Steven H Kroft, Alexandra M Harrington, et al.
American Journal of Clinical Pathology|February 17, 2012
Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapyJames Vaughan, Alexandra M Harrington, Parameswaran N Hari, et al.
Annals of Diagnostic Pathology|November 4, 2016
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysisJason C Chang, Alexandra M Harrington, Horatiu Olteanu, et al.
International Journal of Laboratory Hematology|September 15, 2018
Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature reviewShira Ronen, Steven H Kroft, Horatiu Olteanu, et al.
Journal of Cutaneous Pathology|January 21, 2021
Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patientLeah A Cardwell, Jacquelyn Majerowski, Yvonne E Chiu, et al.
Southern Medical Journal|April 18, 2026
Reimagining Medical Educator Development: A Mixed-Methods Evaluation of KinetiC3, A Longitudinal, Character-Integrated Teaching AcademyKristina Kaljo, Austin Tubbs, Alexandra M Harrington, et al.
American Journal of Clinical Pathology|December 22, 2010
CD23 expression in follicular lymphoma: clinicopathologic correlationsHoratiu Olteanu, Timothy S Fenske, Alexandra M Harrington, et al.
American Journal of Clinical Pathology|July 15, 2016
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk SubtypesAlexandra M Harrington, Lindsay A Schelling, Atousa Ordobazari, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
American Journal of Blood Research|July 5, 2012
Time and temperature stability of T-cell subsets evaluated by a dual-platform methodHoratiu Olteanu, Bernard C Schur, Alexandra M Harrington, et al.
British Journal of Haematology|May 12, 2010
Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemiaHoratiu Olteanu, Alexandra M Harrington, Sarah Ramirez, et al.
Annals of Diagnostic Pathology|July 5, 2011
Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32)J Noelle Buonaccorsi, Steven H Kroft, Alexandra M Harrington, et al.
American Journal of Clinical Pathology|February 17, 2012
Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapyJames Vaughan, Alexandra M Harrington, Parameswaran N Hari, et al.
Annals of Diagnostic Pathology|November 4, 2016
Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysisJason C Chang, Alexandra M Harrington, Horatiu Olteanu, et al.
International Journal of Laboratory Hematology|September 15, 2018
Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature reviewShira Ronen, Steven H Kroft, Horatiu Olteanu, et al.
Journal of Cutaneous Pathology|January 21, 2021
Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patientLeah A Cardwell, Jacquelyn Majerowski, Yvonne E Chiu, et al.
Southern Medical Journal|April 18, 2026
Reimagining Medical Educator Development: A Mixed-Methods Evaluation of KinetiC3, A Longitudinal, Character-Integrated Teaching AcademyKristina Kaljo, Austin Tubbs, Alexandra M Harrington, et al.
American Journal of Clinical Pathology|December 22, 2010
CD23 expression in follicular lymphoma: clinicopathologic correlationsHoratiu Olteanu, Timothy S Fenske, Alexandra M Harrington, et al.
American Journal of Clinical Pathology|July 15, 2016
Immunophenotypes of Chronic Myelomonocytic Leukemia (CMML) Subtypes by Flow Cytometry:  A Comparison of CMML-1 vs CMML-2, Myeloproliferative vs Dysplastic, De Novo vs Therapy-Related, and CMML-Specific Cytogenetic Risk SubtypesAlexandra M Harrington, Lindsay A Schelling, Atousa Ordobazari, et al.
Pageof 5